8x growth unlocked by Enzyme.Myso! 📈 Super excited to share a big milestone, Enzyme.Myso v3 has now crossed $40M+ in YTD notional volume (a record 8x growth in three months), with $1.5M+ in premiums paid to users and $172K in protocol fees. 💪 What’s even more exciting: we’re seeing DAOs, asset managers, and treasuries move from pilots to real adoption of on-chain structured products. Every new strategy, every integration is helping push this space forward. If you’re interested in how on-chain options and structured products can unlock new opportunities for your treasury, I’d love to connect!